Dr. Patrick J. Bergin, MD

Dr. Bergin practices at McKenzie Medical Imaging in Springfield, Oregon.

Dr. Bergin's NPI, 1225309685, was assigned on January 17, 2012. Dr. Bergin holds Oregon license MD150855.

Dr. Bergin's primary practice is McKenzie Medical Imaging, at 960 N 16th St Ste 10, Springfield, OR 97477. The practice phone is (541) 726-4694.

Dr. Bergin's primary practice is McKenzie Medical Imaging in Springfield, Oregon. Dr. Bergin is also affiliated with McKenzie-Willamette Medical Center. The medical group on file is Quorum Health. Dmand AI also links Dr. Bergin to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Bergin's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergin practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bergin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bergin is licensed in Oregon.

CMS data shows 1,442 Medicare services from Dr. Bergin across 21 procedure codes in 2024, for 915 Medicare patients. Medicare paid $81,670 for them.

CMS counts 915 Medicare patients who saw Dr. Bergin in 2024. The largest group is 65 to 74, with 375 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bergin's median patient age at 75, with 51% women.

In 2024, Dr. Bergin wrote 3,523 Medicare Part D claims for 604 patients. 84% of them were for generic drugs. CMS names the drug for 3,344 of them, across 37 drugs with 11 or more claims each, at $641,256 in total drug cost. In 2023, CMS named 3,106 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bergin for performance year 2024, reported as part of a group. Dr. Bergin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of coronary angioplasty and stenting by Dr. Bergin, more than 67% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 509 general payments to Dr. Bergin from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Boston Scientific Corporation paid the most, $3,689.